Inhaled Iloprost for Severe Pulmonary Hypertension
Author(s) -
Horst Olschewski,
Gérald Simonneau,
Nazzareno Galiè,
T. W. Higenbottam,
Robert Naeije,
Lewis J. Rubin,
Sylvia Nikkho,
Rudolf Speich,
Marius M. Hoeper,
Jürgen Behr,
Jörg Winkler,
Olivier Sitbon,
Wladimir Popov,
Hossein A. Ghofrani,
Alessandra Manes,
David G. Kiely,
R Ewert,
Andreas Meyer,
Paul A. Corris,
Marion Delcroix,
Miguel Ángel GómezSánchez,
Harald Siedentop,
Werner Seeger
Publication year - 2002
Publication title -
new england journal of medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 19.889
H-Index - 1030
eISSN - 1533-4406
pISSN - 0028-4793
DOI - 10.1056/nejmoa020204
Subject(s) - iloprost , medicine , pulmonary hypertension , placebo , prostacyclin , hemodynamics , inhalation , anesthesia , cardiology , alternative medicine , pathology
Uncontrolled studies suggested that aerosolized iloprost, a stable analogue of prostacyclin, causes selective pulmonary vasodilatation and improves hemodynamics and exercise capacity in patients with pulmonary hypertension.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom